Clinical Trial Update: A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation [Phase 3]

View source ↗

Summary

Phase 3 trial comparing risperidone to placebo for the treatment of conduct disorder in children with mild to borderline mental retardation; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Conduct Disorder
• Disruptive Behavior Disorder
• Oppositional Defiant Disorder

Drugs mentioned

• Risperdal (risperidone)

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Conduct Disorder, Disruptive Behavior Disorder | Phase 3 | Status: COMPLETED